Relying on its in-depth knowledge of allergic diseases and its unparalleled expertise in allergen immunotherapy (AIT) spanning more than 50 years, Stallergenes offers a comprehensive approach in order to improve the lives of allergy sufferers. The company thus offers a wide range of products, from diagnostics to allergen immunotherapy treatments; the only background allergy treatment which acts directly on the immune system.
Stallergenes offers its solutions to combat allergies in 75 countries thanks to a direct presence in 20 countries and a significant network of distributors and partners. The company has doubled its number of subsidiaries in three years, allowing it to offer solutions in areas with substantial and unmet needs.
For further information on Stallergenes, please visit our Corporate Website.